stroke
Successful clinical outcomes for drug treating rare stroke condition
April 25, 2025Research and Development Bioxodes, Neurology, clinical trial, stroke
Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …
American Heart Association awards $2.1m to research link between migraine, strokes and CVD
July 27, 2023Research and Development American Heart Association, Cardiology, cvd, migraine, stroke
The American Heart Association has announced that it will fund seven new scientific research studies to learn more about the …
NHS given guidance on offering genetic testing to stroke patients
May 19, 2023Medical Communications NHS, Neurology, blood clot, genetic testing, stroke
The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …
New Johnson & Johnson study aiming to add stroke detection to Apple Watch
February 26, 2020Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke
Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …
Boehringer’s Pradaxa fails to meet Phase 3 endpoint in preventing recurrent stroke
May 20, 2019Research and Development, Sales and Marketing Boehringer, Pradaxa, pharma, stroke, trial failure
Boehringer has announced that Pradaxa (dabigatran etexilate mesylate) has failed to meet its primary endpoint in its Phase 3 study, …
Heart drugs show promise in stroke and dementia
April 25, 2019Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke
Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …
China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk
January 25, 2019Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke
Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …
Biogen halts Tysabri trial after failure in acute ischemic stroke
February 8, 2018Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure
Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …
Incidence of strokes in younger people rising
February 1, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, stroke
On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …
12% of the UK have hearts ten years older than they are, Public Health England finds
September 4, 2017Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke
New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …
ReNeuron’s stem cell therapy improves motor function in stroke study
December 5, 2016Research and Development ReNeuron, stem cell, stem cell therapy, stroke
ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …
MSD drops osteoporosis trial drug due to stroke risk
September 5, 2016Research and Development, Sales and Marketing MSD, Merck, Odanacatib, osteoporosis, stroke
MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …
AstraZeneca’s Brilinta fails to best aspirin in treating stroke patients
March 23, 2016Research and Development AstraZeneca, Brilinta, stroke
AstraZeneca has announced top-line results from the Phase III SOCRATES trial, confirming that twice-daily doses of its drug Brilinta (ticagrelor) failed …
Flu jab reduces risk of stroke for two months
October 6, 2015Research and Development flu vaccine, stroke
The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …
Bayer launches major new stroke trial
January 27, 2015Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke
Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …
